Lineage, Inc. Common Stock (LINE)vsWelltower Inc (WELL)
LINE
Lineage, Inc. Common Stock
$42.36
+4.23%
REAL ESTATE · Cap: $10.62B
WELL
Welltower Inc
$236.92
+0.39%
REAL ESTATE · Cap: $166.86B
Smart Verdict
WallStSmart Research — data-driven comparison
Welltower Inc generates 138% more annual revenue ($12.76B vs $5.36B). WELL leads profitability with a 12.1% profit margin vs -2.7%. WELL earns a higher WallStSmart Score of 57/100 (C).
LINE
Hold36
out of 100
Grade: F
WELL
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-89.9%
Fair Value
$124.92
Current Price
$236.92
$112.00 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 39.1% year-over-year
Conservative balance sheet, low leverage
Large-cap with strong market position
Earnings expanding 35.6% YoY
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
ROE of 3.3% — below average capital efficiency
Expensive relative to growth rate
Premium valuation, high expectations priced in
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : WELL
The strongest argument for WELL centers on Revenue Growth, Debt/Equity, Market Cap. Revenue growth of 39.1% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : WELL
The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 103.4x leaves little room for execution misses.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while WELL is a growth play — different risk/reward profiles.
LINE carries more volatility with a beta of 0.91 — expect wider price swings.
WELL is growing revenue faster at 39.1% — sustainability is the question.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
WELL scores higher overall (57/100 vs 36/100) and 39.1% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Welltower Inc
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?